CL2008001765A1 - Compounds derived from n- (3-phenyl-benzo [d] isoxazol-6-yl) -2-hydroxy-3,5-diiodo-benzamide; Preparation process; pharmaceutical composition comprising said compound; Preparation process; and use of the compound in the treatment of endo- and ectoparasite infections. - Google Patents
Compounds derived from n- (3-phenyl-benzo [d] isoxazol-6-yl) -2-hydroxy-3,5-diiodo-benzamide; Preparation process; pharmaceutical composition comprising said compound; Preparation process; and use of the compound in the treatment of endo- and ectoparasite infections.Info
- Publication number
- CL2008001765A1 CL2008001765A1 CL2008001765A CL2008001765A CL2008001765A1 CL 2008001765 A1 CL2008001765 A1 CL 2008001765A1 CL 2008001765 A CL2008001765 A CL 2008001765A CL 2008001765 A CL2008001765 A CL 2008001765A CL 2008001765 A1 CL2008001765 A1 CL 2008001765A1
- Authority
- CL
- Chile
- Prior art keywords
- compound
- preparation process
- endo
- benzamide
- benzo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Compuestos derivados de benzo[d]isoxazolil benzamida; procedimiento de preparación; composición farmacéutica que comprende a dicho compuesto; procedimiento de preparación; y uso del compuesto en el tratamiento de infecciones por endo- y ectoparásitos.Compounds derived from benzo [d] isoxazolyl benzamide; preparation procedure; pharmaceutical composition comprising said compound; preparation procedure; and use of the compound in the treatment of endo- and ectoparasite infections.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07110338 | 2007-06-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2008001765A1 true CL2008001765A1 (en) | 2008-12-19 |
Family
ID=38603183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2008001765A CL2008001765A1 (en) | 2007-06-15 | 2008-06-13 | Compounds derived from n- (3-phenyl-benzo [d] isoxazol-6-yl) -2-hydroxy-3,5-diiodo-benzamide; Preparation process; pharmaceutical composition comprising said compound; Preparation process; and use of the compound in the treatment of endo- and ectoparasite infections. |
Country Status (5)
Country | Link |
---|---|
AR (1) | AR066980A1 (en) |
CL (1) | CL2008001765A1 (en) |
PA (1) | PA8783901A1 (en) |
TW (1) | TW200916100A (en) |
WO (1) | WO2008152081A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102206152A (en) * | 2011-04-12 | 2011-10-05 | 浙江荣耀化工有限公司 | Method for chemically synthesizing 3,5-diio-2-hydroxybenzene formyl chloride |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE621597A (en) * | ||||
ZA731553B (en) * | 1972-03-07 | 1974-10-30 | Janssen Pharmaceutica Nv | Salicylanilide derivatives |
DE2220629C3 (en) * | 1972-04-27 | 1981-01-22 | Bayer Ag, 5090 Leverkusen | Benzisoxazolo (thiono) phosphorus (phosphonic) acid esters, process for their preparation and their use as insecticides and acaricides |
US4005218A (en) * | 1975-03-18 | 1977-01-25 | Janssen Pharmaceutica N.V. | Antiparasitic salicylanilide derivatives |
US4212865A (en) * | 1978-12-26 | 1980-07-15 | Riker Laboratories, Inc. | Amine derivatives of 2-nitro-3-phenylbenzofuran |
US5256681A (en) * | 1989-03-15 | 1993-10-26 | Janssen Pharmaceutica N.V. | [5(6)-(benzisoxa-,benzisothia-or indazol-3-yl)-1H-benzimidazol-2-yl]carbamates |
-
2008
- 2008-06-10 PA PA20088783901A patent/PA8783901A1/en unknown
- 2008-06-12 WO PCT/EP2008/057348 patent/WO2008152081A2/en active Application Filing
- 2008-06-12 AR ARP080102514A patent/AR066980A1/en unknown
- 2008-06-13 CL CL2008001765A patent/CL2008001765A1/en unknown
- 2008-06-13 TW TW097122027A patent/TW200916100A/en unknown
Also Published As
Publication number | Publication date |
---|---|
PA8783901A1 (en) | 2009-01-23 |
WO2008152081A3 (en) | 2009-05-28 |
WO2008152081A2 (en) | 2008-12-18 |
AR066980A1 (en) | 2009-09-23 |
TW200916100A (en) | 2009-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2007001392A1 (en) | Compounds derived from quinoline or benzopyran hiv replication inhibitors; pharmaceutical composition comprising said compounds; and its use in the treatment of a hiv infection | |
CL2008003406A1 (en) | Quinoline derived compounds; pharmaceutical composition comprising them; and use in the treatment of an HIV infection. | |
CL2008002369A1 (en) | Compounds derived from pyridin-3-yl-oxypyridin-2-yl-amino, alk5 inhibitors; pharmaceutical composition comprising said compound; and use of the compound in the treatment of cancer. | |
CL2008001855A1 (en) | Boron-derived condensed cyclic compounds; pharmaceutical composition; and use in the treatment and / or prevention of an infectious disease. | |
CL2007000806A1 (en) | COMPOUNDS DERIVED FROM REPLACED HETEROPENTACICLOS; PREPARATION PROCESS; INTERMEDIARY COMPOUNDS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF CANCER. | |
CL2007003686A1 (en) | COMPOUNDS DERIVED FROM INDOL WITH UNITED RING IN POSITIONS 4,5; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND TO TREAT A VIRAL INFECTION. | |
CL2007002207A1 (en) | COMPOUNDS DERIVED FROM SULFONYLAMINES; PHARMACEUTICAL COMPOSITION; AND USE OF COMPOUNDS IN THE TREATMENT OF GLAUCOMA. | |
SV2009002865A (en) | USE OF OXAZOLIDINONES FOR THE TREATMENT AND PROFILAXIS OF MICROANGIOPATIAS | |
CL2009000483A1 (en) | Compounds derived from n- (pyridin-3-yl) -1,3-thiazole-5-amino-4-carboxamide, pim kinase inhibitors; pharmaceutical composition; and use for the treatment of cancer. | |
CL2007003250A1 (en) | COMPOUNDS DERIVED FROM ISOQUINOLINE, INHIBITORS OF THE HEPATITIS C VIRUS; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF AN HCV INFECTION. | |
CL2008001170A1 (en) | Compounds derived from chromans and naphthalene substituted with a heterocyclic ring; pharmaceutical composition; and its use in the treatment of acute or chronic nociceptive pain or pain, visceral pain, inflammatory and / or central or peripheral neuropathic pain. | |
CL2007002018A1 (en) | COMPOUNDS DERIVED FROM SUBSTITUTED ISOXAZOLINS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION; AND USE OF THE COMPOUND FOR THE TREATMENT OF A DISEASE CAUSED BY AN INCREASE IN THE CELL PROLIFERATION. | |
UY31673A1 (en) | "UREA HETEROCYCLIC DERIVATIVES AND METHODS OF USE OF THE SAME-211" | |
CL2007001992A1 (en) | COMPOUNDS DERIVED FROM PYRIMIDILCICLOPENTANOS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE TREATMENT OF AN INFLAMMATORY, HYPERPROLIFERANT, CARDIOVASCULAR, NEURODEGE DISEASE | |
CL2008003405A1 (en) | Compounds derived from thienopyridine, inhibitors of the hiv integrase enzyme; pharmaceutical composition comprising said compounds; and its use to treat an HIV infection. | |
CL2007000601A1 (en) | Compounds derived from pyrazolic heterobicycles, inhibitors of thyroxine kinase protein activity; pharmaceutical composition comprising said compounds; and use of the compounds in the treatment of a hyperproliferative disease. | |
CL2008003511A1 (en) | Nucleotide derived compounds, hepatitis c virus ns5b polymerase inhibitors; pharmaceutical composition comprising said compound; and use of the compound for the treatment of hepatitis c. | |
CL2007002890A1 (en) | Compounds derived from 2-pyridinecarboxamide, glucosinase activator; pharmaceutical composition; and use of the compound for the treatment of diabetes or obesity. | |
CL2007001205A1 (en) | Compounds derived from n-phenyl-3-thio-4-phenyl-azetedin-2-one; preparation procedure; pharmaceutical composition; combination; use in the treatment of a hyperlipidemic condition, atherosclerosis, Alzheimer's and cholesterol-associated tumors | |
CL2011002925A1 (en) | Isoquinolin-1 (2h) -one derived compounds, selective inhibitors of poly (adp-ribose) polymerase parp-1 activity; process to prepare them; pharmaceutical composition; and its use to treat a disease mediated by the protein parp-1. | |
CL2007002346A1 (en) | NON-NUCLEOSIDIC COMPOUNDS DERIVED FROM FENOXI-FENIL SUBSTITUTED, INHIBITORS OF THE HIV REVERSE TRANSCRIPT; PHARMACEUTICAL COMPOSITION; AND ITS USE TO TREAT PREVENT AN HIV INFECTION OR TO TREAT AIDS OR CRS. | |
CL2007003540A1 (en) | COMPOUNDS DERIVED FROM MACROCICLES, INHIBITORS OF THE SERINE PROTEASE OF HEPATITIS C; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF HEPATITIS C. | |
CL2007000918A1 (en) | COMPOUNDS DERIVED FROM ENFUMAFUNGINA, INHIBITORS OF (1,3) -BETA-D-GLUCANOSINTETASE; PHARMACEUTICAL COMPOSITION; AND USE TO TREAT A FUNGICAL INFECTION. | |
CL2008002049A1 (en) | Macrocyclic aminoindole derived compounds; pharmaceutical composition comprising said compound; and use of the compound for the treatment of hepatitis c. | |
CL2008002689A1 (en) | Compounds derived from heterocycle 1,4 substituted piperidine; intermediate compounds; pharmaceutical composition; Preparation process; and its use in the treatment of Alzheimer's and schizophrenia. |